Volume 199, Issue 1, Supplement , Pages S11-S20, January 2010
Prevention and management of venous thromboembolism in the surgical patient: options by surgery type and individual patient risk factors
To access this article, please choose from the options below
Dr Muntz is a member of the advisory boards of Boehringer Ingelheim, Johnson & Johnson, and sanofi-aventis; a consultant for Bayer AG, Boehringer Ingelheim GmbH, sanofi-aventis, and Johnson & Johnson; and a member of the speakers' bureau of sanofi-aventis. Dr Michota is a member of the advisory boards of sanofi-aventis, Osaka Pharmaceuticals, Genentech Inc, and Ortho-McNeil/Johnson & Johnson and is a consultant and a member of the speakers' bureau of sanofi-aventis, Osaka Pharmaceuticals, and Genentech Inc.
PII: S0002-9610(09)00646-1
doi:10.1016/j.amjsurg.2009.10.007
© 2010 Elsevier Inc. All rights reserved.
Volume 199, Issue 1, Supplement , Pages S11-S20, January 2010
